Kenneth J. Wiggall

Publications by Year

Research Areas

Ion Transport and Channel Regulation, ATP Synthase and ATPases Research, Drug Transport and Resistance Mechanisms, Glycosylation and Glycoproteins Research, Platelet Disorders and Treatments

Most-Cited Works

• → New IDH1 mutant inhibitors for treatment of acute myeloid leukemia(2015)176 cited
• → 3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase(2006)160 cited
• → Hydrazinonaphthalene and Azonaphthalene Thrombopoietin Mimics Are Nonpeptidyl Promoters of Megakaryocytopoiesis(2001)119 cited
• → Identification of a Pharmacophore for Thrombopoietic Activity of Small, Non-Peptidyl Molecules. 1. Discovery and Optimization of Salicylaldehyde Thiosemicarbazone Thrombopoietin Mimics(2002)87 cited
• → Identification of a Pharmacophore for Thrombopoietic Activity of Small, Non-Peptidyl Molecules. 2. Rational Design of Naphtho[1,2-d]imidazole Thrombopoietin Mimics(2002)59 cited
• → Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogs of 4-(arylamino)quinolines(1990)58 cited
• → Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent(1992)56 cited
• → Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-Substituted-4-(phenylamino)quinolines(1992)53 cited
• → Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase(2009)45 cited
• → Discovery of SB-497115, a Small-Molecule Thrombopoietin (TPO) Receptor Agonist for the Treatment of Thrombocytopenia.(2004)28 cited